FDANovember 21, 2023device

DxI 9000 Access Immunoassay Analyzer running software version 1.16 or prior,

Official recall recorded by the U.S. Food & Drug Administration.

The hazard

There are potential performance issues found in the DxI 9000 Access Immunoassay Analyzer, including: 1) Access Ultrasensitive Insulin users who configure SI units (pmol/L) applies an incorrect conversion factor; 2) System provides numerical results that are below the lowest reportable result if laboratory chooses to report assay results in units of measurement other than the defined default units; 3) A result of 0 incorrectly reported when the system utilizes an expression that utilizes non-numerical symbols (e.g., > or <) to derive a calculated test as part of result reporting; 4) Reserve volume is enabled and the assay LIS code is not the same as the assay Test ID. These issues could potentially lead to erroneous results or delay reporting results for multiple analytes.

What to do

FDA enforcement status: Ongoing

Brands named

beckman coulterbeckman

UPCs

15099590732103300148300146300204300207

Recall history

Other federal recalls tied to the same brand — a factual pattern, straight from the source data.

Own something like this?

AllClear screens your whole list against every CPSC, FDA, USDA and NHTSA recall — and tells you the day a new one names something you own.

Start free — 200 items, no card →
DxI 9000 Access Immunoassay Analyzer running software version 1.16 or prior, — Recall Details · AllClear